MPEG LA Initiative to Address CRISPR Licensing

One-stop access will accelerate advances in new medicines, organ transplants and agriculture

DENVER -Wednesday, December 7th 2016 [ ME NewsWire ]

(BUSINESS WIRE)-- World licensing leader MPEG LA, LLC announced today an initiative to address the need for an efficient one-stop license alternative around CRISPR, a breakthrough technology that enables cellular DNA to be edited quickly and inexpensively. Some CRISPR patents are currently the subject of an interference proceeding (No. 106048) among various patent holders and applicants before the US Patent and Trademark Office.

“CRISPR’s wide range of potential applications in medicine and agriculture, and the steadily increasing volume of intellectual property in the field, point to the need for a one-stop licensing platform to reduce litigation risk and provide efficiency, transparency and predictability to scientists and businesses worldwide,” said MPEG LA President and CEO Larry Horn. “Our worldwide licensing infrastructure, trusted reputation for independence, experience, impartiality and results with patent pools, and relationships with industry and academia, including life sciences, position MPEG LA to deliver a licensing solution for the life sciences market as it did with digital video for the consumer electronics market.”

“We are mapping the CRISPR Cas-9 patent landscape as a tool for identifying essential patents to be licensed together in a single transaction for various genome engineering applications on a worldwide basis,” said Kristin Neuman, MPEG LA Executive Director of Biotechnology Licensing, “and will incorporate other genomic engineering technologies as they emerge.”

MPEG LA welcomes the participation of the CRISPR community. A mapping reference model defining the license coverage that will free developers to focus on creating quality-of-life enhancing products while compensating inventors is expected to be available soon. Updates may be found on MPEG LA’s CRISPR page at http://www.mpegla.com/main/pid/CRISPR/default.aspx. For more information, please email biotech@mpegla.com.

MPEG LA, LLC

MPEG LA is the world’s leading provider of one-stop licenses for standards and other technology platforms. Starting in the 1990s, it pioneered the modern-day patent pool helping to produce the most widely used standards in consumer electronics history. MPEG LA has operated licensing programs for a variety of technologies consisting of more than 13,000 patents in 82 countries with some 230 patent holders and more than 6,000 licensees. By assisting users with implementation of their technology choices, MPEG LA offers licensing solutions that provide access to fundamental intellectual property, freedom to operate, reduced litigation risk and predictability in the business planning process. In turn, this enables inventors, research institutions and other technology owners to monetize and speed market adoption of their assets to a worldwide market while substantially reducing the cost of licensing. For more information, go to www.mpegla.com.

 


Contacts

MPEG LA, LLC

Tom O’Reilly, 303-200-1710

Fax: 301-986-8575

toreilly@mpegla.com





Permalink : http://me-newswire.net/news/2928/en

Permalink : http://me-newswire.net/news/2928/en